57
Retinopathy Ridwan Hadinata Salim (I11109037)

Retinopathy.ppt

  • Upload
    reganjm

  • View
    53

  • Download
    0

Embed Size (px)

DESCRIPTION

Retinopathy.ppt

Citation preview

  • 5/28/2018 Retinopathy.ppt

    1/57

    RetinopathyRidwan Hadinata Salim

    (I11109037)

  • 5/28/2018 Retinopathy.ppt

    2/57

    Definition

    General term that refers to some form of

    non-inflammatory damage to the retina of the

    eye.

    Frequently, retinopathy is an ocular

    manifestation of systemic disease.

  • 5/28/2018 Retinopathy.ppt

    3/57

    DIABETIC RETINOPATHY

  • 5/28/2018 Retinopathy.ppt

    4/57

    Definition

    Progressive dysfunction of the retinal blood

    vessels caused by chronic hyperglycemia.

    Diabetic Retinopathy can be a complication of

    diabetes type 1 or diabetes type 2.

    Initially, Diabetic Retinopathy is asymptomatic,

    if not treated though it can cause low vision and

    blindness.

  • 5/28/2018 Retinopathy.ppt

    5/57

    Diabetic retinopathy symptoms

    Diabetic retinopathy is asymptomatic in early stages of thedisease

    As the disease progresses symptoms may include

    Blurred vision

    Floaters

    Fluctuating vision

    Distorted vision

    Dark areas in the vision

    Poor night vision

    Impaired color vision

    Partial or total loss of vision

  • 5/28/2018 Retinopathy.ppt

    6/57

    Risk factors

    Duration of diabetes

    Poor Blood Sugar control Hypertension

    Hyperlipidemia

    Barriers to care

  • 5/28/2018 Retinopathy.ppt

    7/57

    Risk factors Diabetic Retinopathy

    Duration of diabetes is a major riskfactor associated with the development

    of diabetic retinopathy

    The severity of hyperglycemia is the key

    alterable risk factor associated with thedevelopment of diabetic retinopathy

  • 5/28/2018 Retinopathy.ppt

    8/57

    How diabetes cause vision loss

    HOW DIABETES CAUSES VISION LOSS

    Preclinical

    changes

    Macular

    edema

    ProliferativeDR

    DiabetesBackground

    DR

    Clinical

    significant

    macular edema

    Vitreous hemorrhage

    and/or Retinaldetachment and/or

    neovascular glaucoma

    PreproliferativeDR

    Vision

    loss

  • 5/28/2018 Retinopathy.ppt

    9/57

    Pathophysiology

    Diabetic Retinopathy is a microvasculopathy

    that causes:

    Retinal capillary occlusion

    Retinal capillary leakage

  • 5/28/2018 Retinopathy.ppt

    10/57

    Microvascular Occlusion

    Microvascular occlusion is caused by:

    Thickening of capillary basement membranes

    Abnormal proliferation of capillary endothelium

    Increased platelet adhesion Increased blood viscosity

    Defective fibrinolysis

  • 5/28/2018 Retinopathy.ppt

    11/57

    Cottonwool spot

    Neovascularization

    Ischemia

    Neovascular

    glaucoma

    Microvascular

    Occlusion

    Fibrovascular bandsVitreous

    hemorrhage

    Increased VEFG

    Tractional retinal

    detachment

    Infarction

  • 5/28/2018 Retinopathy.ppt

    12/57

    Microvascular leakage

    Microvascular leakage is caused by:

    Impairment of endothelial tight junctions

    Loss of pericytes

    Weakening of capillary walls Elevated levels of vascular endothelial growth factor (VEGF)

  • 5/28/2018 Retinopathy.ppt

    13/57

    EdemaRetinal

    hemorrhageHard exudates

    Microvascular Leakage

  • 5/28/2018 Retinopathy.ppt

    14/57

    Classification of diabetic retinopathy

    A useful classification according to the types oflesions detected on fundoscopy is as follows:

    Non-proliferative diabetic retinopathy (NPDR)

    Proliferative diabetic retinopathy

    Maculopathy

  • 5/28/2018 Retinopathy.ppt

    15/57

    No retinopathy

  • 5/28/2018 Retinopathy.ppt

    16/57

    MILD NONPROLIFERATIVE DIABETIC

    RETINOPATHY

    Characteristics

    Microaneurysms only

  • 5/28/2018 Retinopathy.ppt

    17/57

    Microaneurysms

    Retinal microaneurysms are focal dilatations of retinal

    capillaries, 10 to 100 microns in diameter, and appear as reddots. They are usually seen at the posterior pole, especiallytemporal to the fovea. They may apparently disappear whilstnew lesions appear at the edge of areas of widening capillarynon-perfusion. Microaneurysms are the first

    ophthalmoscopically detectable change in diabeticretinopathy.

    Beginning as dilatations in areas in the capillary wall wherepericytes are absent, microaneurysms are initially thin-walled.Later, endothelial cells proliferate and lay down layers ofbasement membrane material around themselves.

  • 5/28/2018 Retinopathy.ppt

    18/57

    Fibrin and erythrocytes may accumulate within the aneurysm.

    Despite multiple layers of basement membrane, they are

    permeable to water and large molecules, allowing the

    accumulation of water and lipid in the retina. Since

    fluorescein passes easily through them, many moremicroaneurysms are usually seen on fluorescein angiography

    than are apparent on ophthalmoscopy

  • 5/28/2018 Retinopathy.ppt

    19/57

    MILD NONPROLIFERATIVE DIABETIC

    RETINOPATHY

    Microaneurysms

  • 5/28/2018 Retinopathy.ppt

    20/57

    Moderate Nonproliferative Diabetic

    Retinopathy (NPDR)

    Characteristics

    More than just microaneurysms but less than severe NPDR

  • 5/28/2018 Retinopathy.ppt

    21/57

    Moderate Nonproliferative Diabetic

    Retinopathy (NPDR)

    Hard exudates

    Flamed shaped

    hemorrhage

    Microaneurysm

  • 5/28/2018 Retinopathy.ppt

    22/57

    Moderate Nonproliferative Diabetic

    Retinopathy (NPDR)

    Hard exudates

    microaneurysm

  • 5/28/2018 Retinopathy.ppt

    23/57

    Severe Nonproliferative Diabetic

    Retinopathy (NPDR)

    Any of the following:

    More than 20 intraretinal hemorrhages in each of

    four quadrants

    Definite venous beading in two or more quadrants

    Prominent Intraretinal Microvascular Abnormalities

    (IRMA) in one or more quadrants

    No signs of proliferative retinopathy

  • 5/28/2018 Retinopathy.ppt

    24/57

    Severe Nonproliferative Diabetic Retinopathy

    (NPDR)

    Venous beading

  • 5/28/2018 Retinopathy.ppt

    25/57

    Proliferative Diabetic Retinopathy (PDR)

    Characteristics

    Neovascularization

    Vitreous/preretinal

    hemorrhage

  • 5/28/2018 Retinopathy.ppt

    26/57

    PROLIFERATIVE

    DIABETIC

    RETINOPATHY

    Neovascularization

    Hard exudate

    Cotton-wool

    spot

    Blot hemorrhage

  • 5/28/2018 Retinopathy.ppt

    27/57

    High-Risk Proliferative diabetic retinopathy

    At risk for serious vision loss

    Any combination of three of the following four findings

    Presence of vitreous or preretinal hemorrhage.

    Presence of new vessels (neovascularization, NV) Location of NV on or near the optic disc.

    Moderate to severe extent of new vessels.

  • 5/28/2018 Retinopathy.ppt

    28/57

    Diabetic macular edema

    Diabetic macular edema is the leading cause of legal

    blindness in diabetics.

    Diabetic macular edema can be present at any stage

    of the disease, but is more common in patients withproliferative diabetic retinopathy.

  • 5/28/2018 Retinopathy.ppt

    29/57

    Meta analysis and review on the effect on bevacizumab id diabetic macular edema

    Graefes Arch Clin Exp Ophthalmol(2011) 249:15-27

  • 5/28/2018 Retinopathy.ppt

    30/57

    Why is Diabetic macular edema so important?

    The macula is responsible for central vision.

    Diabetic macular edema may be asymptomatic atfirst. As the edema moves in to the fovea (the centerof the macula) the patient will notice blurry centralvision. The ability to read and recognize faces will becompromised.

    Macula

    Fovea

  • 5/28/2018 Retinopathy.ppt

    31/57

    Normal Macular Edema

  • 5/28/2018 Retinopathy.ppt

    32/57

    Clinically significant macular edema

    (CSME)

    Thickening of the retina at or within 500 m of the

    center of the macula.

    Hard exudates at or within 500 m of the center of

    the macula, if associated with thickening of theadjacent retina.

    Area of retinal thickening 1 disc area or larger, within

    1 disc diameter of the center of the macula.

  • 5/28/2018 Retinopathy.ppt

    33/57

    International Clinical Diabetic Macular Edema

    Disease Severity Scale

    Proposed disease severity level Findings observable upon dilated

    ophthalmoscopy

    DME apparently absent

    DME apparently present

    DME present

    No apparent retinal thickening or hard exudates in

    posterior pole

    Some apparent retinal thickening or hard exudatesin posterior pole

    Mild DME (some retinal thickening or hard exudates

    in posterior pole but distant from the center of the

    macula)

    Moderate DME (retinal thickening or hard

    exudates approaching the center of the macula but

    not involving the center)

    Severe DME (retinal thickening or hard exudates

    involving the center of the macula)Proposed International Clinical DiabeticRetinopathy and Diabetic Macular Edema

    Disease Severity Scales

    Ophthalmology Volume 110, Number 9, September 2003

  • 5/28/2018 Retinopathy.ppt

    34/57

    DIABETIC RETINOPATHY TREATMENT

    The best measure for prevention of

    loss of vision from diabetic

    retinopathy is strict glycemiccontrol

  • 5/28/2018 Retinopathy.ppt

    35/57

    Laser Photocoagulation

    Laser Photocoagulation is recommended for eyes with:

    Clinical significant macular edema CSME

    High risk Proliferative diabetic retinopathy

  • 5/28/2018 Retinopathy.ppt

    36/57

    DIABETIC RETINOPATHY TREATMENT

    Once DR threatens vision treatments can include:

    Laser therapy to seal leaking bloodvessels (focal laser)

    Laser therapy to reduce retinal oxygendemand (scatter laser)

    Surgical removal of blood from the eye(vitrectomy)

  • 5/28/2018 Retinopathy.ppt

    37/57

    DIABETIC RETINOPATHY TREATMENT

    NEWER DEVELOPMENTS:

    The use of anti-vascular endothelial

    growth factor antibodies has beenshown to be useful in the treatment ofDR

    Anti-VEGF antibody treatment appearsto be useful for both macular edema andproliferative retinopathy

    Studies to determine the exact role ofanti-VEGF treatment in relation to lasertreatment in specific situations areunderway.

  • 5/28/2018 Retinopathy.ppt

    38/57

    CONCLUSIONS

    Diabetic Retinopathy is

    preventable through strict

    glycemic control and annual

    dilated eye exams by an

    ophthalmologist.

  • 5/28/2018 Retinopathy.ppt

    39/57

    HYPERTENSIVE

    RETINOPATHY

  • 5/28/2018 Retinopathy.ppt

    40/57

    Hipertensive Retinopathy

    A condition characterized by a spectrum of

    retinal vascular signs in people with elevated

    blood pressure.

    Arterial changes in hypertension are primarily

    caused by vasospasm; in arteriosclerosis they

    are the result of thickeningof the wall of the

    arteriole.

  • 5/28/2018 Retinopathy.ppt

    41/57

    Pathophysiology

    1. Vasoconstrictive stage

    2. Sclerotic stage

    3. Exudative stage

  • 5/28/2018 Retinopathy.ppt

    42/57

    Pathophysiology

    Vasoconstrictive stage

    blood pressure

    Retinal arteriol vasoconstrictive

    (local autoregulatory mechanisms)

    Generalized narrowing of the

    retinal arterioles.

  • 5/28/2018 Retinopathy.ppt

    43/57

    Sclerotic stage

    Persistently elevated blood pressure

    Intimal thickening, media wallhyperplasia, hyaline degeneration

    Changes in the arteriolar andvenular junction (arteriovenous

    nicking or nipping)

  • 5/28/2018 Retinopathy.ppt

    44/57

    Exudative stage

    Disruption of the bloodretina barrier

    Necrosis of the smooth muscles andendothelial cells exudation of blood

    and lipids, and retinal ischemia

    Microaneurysms, hemorrhages, hard

    exudates, and cotton-wool spots.

  • 5/28/2018 Retinopathy.ppt

    45/57

  • 5/28/2018 Retinopathy.ppt

    46/57

    Classifications

    Arteriolar Sclerosis Aging causes thickening and sclerosis of the

    arterioles

    Prolonged systemic hypertension (usually diastolicpressure greater than100 mm Hg).

    The amount of arteriolar sclerosis depends on

    duration and severity of the hypertension and

    may reflection the condition of the arterioleselsewhere in the body.

  • 5/28/2018 Retinopathy.ppt

    47/57

    Elevated Blood Pressure

    A moderate acute rise in blood pressure results inconstriction of the arterioles.

    A severe acute rise in blood pressure (usually, diastolic

    pressure greater than 120 mmHg) causes fibrinoid

    necrosis of the vessel wall, resulting in exudates,cotton-wool spots, flame-shaped hemorrhages, and

    sometimes whitish swelling and edema of large

    portions of the retina.

    In the most severe form of hypertensive retinopathy,malignant hypertension the optic disc swelling that

    occurs resembles the swelling seen in papilledema.

  • 5/28/2018 Retinopathy.ppt

    48/57

    Hypertensive retinopathy: haemorrhages,

    cotton-wool spots, exudates, vascular calibre

    changes.

  • 5/28/2018 Retinopathy.ppt

    49/57

  • 5/28/2018 Retinopathy.ppt

    50/57

  • 5/28/2018 Retinopathy.ppt

    51/57

  • 5/28/2018 Retinopathy.ppt

    52/57

  • 5/28/2018 Retinopathy.ppt

    53/57

    Symptoms

    Headaches

    Visual disturbances, and sometimes sudden

    vision loss

  • 5/28/2018 Retinopathy.ppt

    54/57

  • 5/28/2018 Retinopathy.ppt

    55/57

    Treatment

    Control of high blood pressure (hypertension)

    is the only treatment for hypertensive

    retinopathy.

  • 5/28/2018 Retinopathy.ppt

    56/57

  • 5/28/2018 Retinopathy.ppt

    57/57

    Thank You